|
Acrivastine
|
|
[ Product introduction ]
|
Treatment for allergic skin disorders, allergic rhinitis, upper respiratory tract disorders, urticaria. Histamine H1 Antagonists
|
|
[ Structural formula ]
|
|
|
[ C A S ] |
87848-99-5 |
|
[ Chemical name ] |
(E)-3-[6-[(E)-1-(4-Methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoicacid |
|
[ Molecular formula ] |
C22H24N2O2 |
|
[ Molecular weight ] |
348.44 |
|
[ Property ] |
White-like needle crystal or crystalline powder; odorless, flavorless, easily soluble in acetone, glacial acetic acid, soluble in ethanol or ethyl acetate, slightly soluble in chloroform or ether, insoluble in water or diluted hydrochloric acid. |
|
[ Packing specification ] |
5Kg / tin, 25Kg / pail |
|
[ Storage ] |
Sealed and stored at room temperature. |
|
[ Executive standard ] |
BP/USP/CP |
|
[ Main index ] |
White-like needle crystal or crystalline powder; odorless,
melting ptoint:220℃～222℃
Content(HPLC):>99%
|
|
[ Quality standard ]
|
Purity (HPLC): >98%
Appearance: gray white to white powdery solid
Loss on dry: <0.5%
Moisture: <0.5%
Melting point: >250°C
|
>>Alphabetical order
